APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
31 hedge funds and large institutions have $29.6M invested in Aptose Biosciences, Inc. in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
99% less call options, than puts
Call options by funds: $2K | Put options by funds: $251K
Holders
31
Holding in Top 10
–
Calls
$2K
Puts
$251K
Top Buyers
| 1 | +$1.78M | |
| 2 | +$1.5M | |
| 3 | +$1.04M | |
| 4 |
Man Group
London,
United Kingdom
|
+$267K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$177K |
Top Sellers
| 1 | -$392K | |
| 2 | -$388K | |
| 3 | -$78K | |
| 4 |
Renaissance Technologies
New York
|
-$56K |
| 5 |
VF
Virtu Financial
New York
|
-$47.5K |